April 16, 2019
CB Therapeutics Announces Closing of the Latest Round of Equity Funding for Scaling Up Biosynthesis Research and Production
-CBTherapeutics, an innovative biotechnology company focusing onresearch and production of wellness compounds, announced the closing ofthe first round of equity funding for its research projects.
